The validity period of online orders: 3 months from the purchase date.
The respiratory syncytial virus vaccine (RSV Vaccine Abrysvo) is designed to protect against respiratory (lung) diseases caused by the respiratory syncytial virus (RSV). It is one of the most common viruses that can cause serious complications in infants, elderly individuals, and those with chronic diseases.
Who is the RSV Vaccine Abrysvo for?
RSV vaccination is recommended for:
- Pregnant women – to protect infants from birth up to 6 months of age.
- Individuals aged 60 and above – to reduce the risk of severe respiratory infections and complications.
What is RSV?
RSV (respiratory syncytial virus) is a commonly spread virus causing mild, cold-like symptoms, such as:
- Sore throat,
- Cough,
- Nasal congestion.
While the illness often resolves easily, RSV can be particularly dangerous for certain groups.
Why is RSV dangerous?
- In infants, RSV can cause serious lung diseases such as bronchiolitis or pneumonia.
- In older adults and those with chronic illnesses (e.g., COPD – chronic obstructive pulmonary disease, CHF – congestive heart failure), RSV can significantly deteriorate health.
- In some cases, RSV infection may require hospitalization and, in severe cases, can result in death.
Why get vaccinated against RSV?
RSV vaccination is a reliable protection method that helps reduce the risk of severe illness, especially for those at the highest risk of complications. The Abrysvo vaccine provides protection for both newborns (through vaccination of the mother during pregnancy) and older individuals.